Article
Characterization of mutations and loss of heterozygosity of p53 and K-ras2 in pancreatic cancer cell lines by immobilized polymerase chain reaction.
BMC biotechnology - 23 Jul 2003
Butz James, Wickstrom Eric, Edwards Jeremy
Abstract excerpt
BACKGROUND: The identification of known mutations in a cell population is important for clinical applications and basic cancer research. In this work an immobilized form of the polymerase chain reaction, referred to as polony technology, was used to detect mutations as well as gene deletions, resulting in loss of heterozygosity (LOH), in cancer cell lines. Specifically, the mutational hotspots in p53, namely...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
